Insight Molecular Diagnostics Inc.
IMDX | NASDAQ
$4.14
+$0.13 (+3.24%)
Sep 22, 2026, 12:39 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 4.06M | 1.88M | 1.5M | 958K | 2.2M | 1.22M |
Cost of Revenue | 3.87M | 1.14M | 1.09M | 976K | 778K | 1.86M |
Gross Profit | 190K | 740K | 413K | -18K | 1.42M | -639K |
Operating Income | -30.58M | -61.04M | -25.14M | -18M | -53.73M | -29.71M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -50.22M | -60.66M | -24.86M | -18.61M | -52.87M | -31.19M |
Net Income | -50.22M | -60.66M | -27.78M | -72.9M | -64.1M | -29.93M |
Selling & General & Admin | 16.98M | 13.79M | 13.29M | 21.53M | 20.39M | 23.28M |
Research & Development | 15.9M | 9.84M | 9.29M | 7.3M | 5.04M | 9.8M |
Other Expenses | -2.11M | 38.16M | 2.97M | -10.86M | 29.72M | -4.01M |
Operating Expenses | 30.77M | 61.78M | 25.55M | 17.98M | 55.15M | 29.07M |
Interest Expense | 109K | 84K | 52K | 83K | 209K | 252K |
Selling & Marketing Expenses | 6.34M | 641K | 307K | 17K | 5K | 6.49M |
Cost & Expenses | 34.63M | 62.92M | 26.64M | 18.96M | 55.92M | 30.93M |
Income Tax Expense | n/a | n/a | n/a | n/a | -9.26M | -1.25M |
Shares Outstanding (Basic) | 30.48M | 13.07M | 7.65M | 5.54M | 4.45M | 3.27M |
Shares Outstanding (Diluted) | 30.48M | 13.07M | 7.65M | 5.54M | 4.45M | 3.27M |
EPS (Basic) | -1.65 | -4.66 | -3.75 | -20 | -14.40 | -9.14 |
EPS (Diluted) | -1.65 | -4.66 | -3.75 | -20 | -14.40 | -9.14 |
EBITDA | -47.92M | -59.02M | -23.12M | -13.31M | -48.46M | -30.54M |
EBIT | -50.11M | -60.58M | -24.8M | -18.53M | -52.66M | -30.93M |
Depreciation & Amortization | 2.2M | 1.56M | 1.68M | 5.22M | 4.21M | 394K |
Add to Watchlist
Select watchlists to add or remove IMDX